Bio-Rad EVP granted 4,313 RSUs, 2,179 vest
Bio-Rad executive Eva Anette Engelhardt had RSUs granted and vest, with some resulting shares withheld to cover costs.
Rhea-AI Filing Summary
BIO-RAD LABORATORIES, INC. (BIO) reported insider equity activity by executive Eva Anette Engelhardt, EVP and President, CDG. On September 4, 2026 she received a grant of 4,313 restricted stock units. On September 5–6, 2026, a total of 2,179 RSUs vested and converted into Class A common shares, with 854 shares delivered or withheld to pay the exercise price or tax liability at $386.11 per share. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
2,179 shares exercised/converted
Exercise
7 txns
Insider
ENGELHARDT EVA ANETTE
Role
EVP, President, CDG
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F2, F4 | 1,152 | $0.00 | $0.00 |
| Exercise | Bio-Rad A Common Stock F1 | 1,152 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Bio-Rad A Common Stock | 485 | $386.11 | $187K |
| Exercise | Restricted Stock Units F2, F4 | 1,027 | $0.00 | $0.00 |
| Exercise | Bio-Rad A Common Stock F1 | 1,027 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Bio-Rad A Common Stock | 369 | $386.11 | $142K |
| Grant/Award | Restricted Stock Units F2, F3 | 4,313 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 9,700 contracts (Direct);
Bio-Rad A Common Stock — 1,828 shares (Direct)
Footnotes (4)
- F1. Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3. The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
- F4. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Key Figures
RSUs granted: 4,313 units
RSUs vested and converted: 2,179 shares
Shares withheld or delivered for costs: 854 shares
+2 more
5 metrics
RSUs granted
4,313 units
Restricted stock units granted to Eva Anette Engelhardt on September 4, 2026
RSUs vested and converted
2,179 shares
Total RSUs that vested and converted into Bio-Rad Class A common stock on September 5–6, 2026
Shares withheld or delivered for costs
854 shares
Shares delivered or withheld to pay exercise price or tax liability at vesting (code F transactions)
Price per share for code F transactions
$386.11 per share
Price applied to 369 and 485 Bio-Rad Class A shares on September 5 and 6, 2026
RSUs vesting period
4 years
New RSU grant vests 25% at first anniversary, remainder in equal quarterly installments
Key Terms
Restricted Stock Units, contingent right, Rule 10b5-1, exercise price or tax liability
4 terms
Restricted Stock Units financial
"Shares of Class A common stock acquired on the vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported for these transactions"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
exercise price or tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
FAQ
What insider equity transactions did BIO (Bio-Rad Laboratories, Inc.) report for Eva Anette Engelhardt?
The filing reports a grant of 4,313 restricted stock units on September 4, 2026, and the vesting and conversion of 2,179 RSUs into Bio-Rad Class A common stock on September 5–6, 2026, with some shares withheld or delivered to cover costs.
How many RSUs were granted to the Bio-Rad (BIO) executive in this Form 4?
Eva Anette Engelhardt received a grant of 4,313 restricted stock units on September 4, 2026. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock, subject to the specified vesting schedule.
Were the Bio-Rad (BIO) insider transactions under a Rule 10b5-1 trading plan?
No. The filing shows the Rule 10b5-1 checkbox as not affirmed, and there is no footnote indicating a pre-arranged Rule 10b5-1 trading plan for these RSU-related transactions.
What is the vesting schedule for the newly granted RSUs in the Bio-Rad (BIO) Form 4?
The 4,313 restricted stock units granted on September 4, 2026 vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
